MedPath

JAIMIESS

These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . Initial U.S. Approval: 1982

Approved
Approval ID

c094e6de-f1e9-9594-43f3-de1c1bb49bdb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 25, 2024

Manufacturers
FDA

Xiromed LLC

DUNS: 080228637

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

levonorgestrel and ethinyl estradiol and ethinyl estradiol tablets

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70700-206
Application NumberANDA200492
Product Classification
M
Marketing Category
C73584
G
Generic Name
levonorgestrel and ethinyl estradiol and ethinyl estradiol tablets
Product Specifications
Effective DateNovember 25, 2024
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

JAIMIESS - FDA Drug Approval Details